1. Home
  2. CIX vs CAPR Comparison

CIX vs CAPR Comparison

Compare CIX & CAPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CIX
  • CAPR
  • Stock Information
  • Founded
  • CIX 1993
  • CAPR 2005
  • Country
  • CIX United States
  • CAPR United States
  • Employees
  • CIX N/A
  • CAPR N/A
  • Industry
  • CIX Industrial Machinery/Components
  • CAPR Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • CIX Consumer Discretionary
  • CAPR Health Care
  • Exchange
  • CIX Nasdaq
  • CAPR Nasdaq
  • Market Cap
  • CIX 296.5M
  • CAPR 324.6M
  • IPO Year
  • CIX 1998
  • CAPR N/A
  • Fundamental
  • Price
  • CIX $22.29
  • CAPR $5.60
  • Analyst Decision
  • CIX
  • CAPR Strong Buy
  • Analyst Count
  • CIX 0
  • CAPR 6
  • Target Price
  • CIX N/A
  • CAPR $23.17
  • AVG Volume (30 Days)
  • CIX 3.1K
  • CAPR 1.5M
  • Earning Date
  • CIX 11-05-2025
  • CAPR 11-10-2025
  • Dividend Yield
  • CIX 9.76%
  • CAPR N/A
  • EPS Growth
  • CIX 2.86
  • CAPR N/A
  • EPS
  • CIX 1.57
  • CAPR N/A
  • Revenue
  • CIX $159,004,000.00
  • CAPR $11,130,509.00
  • Revenue This Year
  • CIX N/A
  • CAPR N/A
  • Revenue Next Year
  • CIX N/A
  • CAPR $7,894.07
  • P/E Ratio
  • CIX $14.10
  • CAPR N/A
  • Revenue Growth
  • CIX 5.52
  • CAPR N/A
  • 52 Week Low
  • CIX $17.89
  • CAPR $5.43
  • 52 Week High
  • CIX $32.97
  • CAPR $20.75
  • Technical
  • Relative Strength Index (RSI)
  • CIX 50.96
  • CAPR 40.44
  • Support Level
  • CIX $21.80
  • CAPR $5.43
  • Resistance Level
  • CIX $22.92
  • CAPR $6.54
  • Average True Range (ATR)
  • CIX 0.54
  • CAPR 0.48
  • MACD
  • CIX 0.09
  • CAPR -0.04
  • Stochastic Oscillator
  • CIX 78.16
  • CAPR 9.09

About CIX CompX International Inc.

Compx International Inc is a manufacturer of security products. Its security products are used in recreational transportation, postal, office & institutional furniture, cabinetry, tool storage, healthcare, and a variety of other industries. Also, it is engaged in the manufacturing of stainless steel exhaust systems, gauges, throttle controls, and trim tabs for the recreational marine industry. The company's operating segment includes Security Products and Marine Components. The company generates maximum revenue from the Security Products segment, which manufactures mechanical and electrical cabinet locks and other locking mechanisms. Its geographical segments are the United States, Canada, Mexico, and others, of which the United States accounts for the vast majority of revenue.

About CAPR Capricor Therapeutics Inc.

Capricor Therapeutics Inc is a clinical-stage biotechnology company focused on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (DMD), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with high unmet medical needs. The company's product pipeline includes CAP-1002, deramiocel an allogeneic cardiac-derived cell therapy. Deramiocel is currently advancing through Phase 3 clinical development for the treatment of Duchenne muscular dystrophy. Through its proprietary StealthXTM platform, the group uses its exosome technology to conduct preclinical research focused on vaccinology, delivering oligonucleotides, proteins, and small molecules to treat.

Share on Social Networks: